Key messages from the FINE-ONE study FINE-ONE is the first randomized Phase 3 study with positive results in CKD associated with T1DM since the 1990s
2 : 811820 Ichijo H, Nishida E, Irie K, ten Dijke P, Saitoh M, Moriguchi T, Takagi M, Matsumoto K, Miyazono K and Gotoh Y (1997) Induction of apoptosis by ASK1, a mammalian MAPKKK that activates SAPK/JNK and p38 signaling pathways
Cardiovascular events and mortality in people with type 2 diabetes and multimorbidity: a real-world study of patients followed for up to 19 years
For all our products we undertake a Rigorous selection of only essential ingredients
Clarithromycin, trimethoprim, and penicillin and oxidative nucleic acid modifications in humans: randomised, controlled trials: Antibiotics and oxidative stress
doi: 10.1111/nure.12077 39